Back to School: How biopharma can reboot drug development. Access exclusive analysis here
SONT acquired Echo for 6.3 million shares worth about $14.9 million based on SONT's close of $2.39 on Sept. 14, the
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury